ID: ALA151389

Max Phase: Preclinical

Molecular Formula: C17H25N5S

Molecular Weight: 331.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1n[nH]c(SCCCN2CCC(Cc3ccccc3)CC2)n1

Standard InChI:  InChI=1S/C17H25N5S/c18-16-19-17(21-20-16)23-12-4-9-22-10-7-15(8-11-22)13-14-5-2-1-3-6-14/h1-3,5-6,15H,4,7-13H2,(H3,18,19,20,21)

Standard InChI Key:  UYSXHRGCOVIZLX-UHFFFAOYSA-N

Associated Targets(Human)

Glutamate [NMDA] receptor subunit epsilon 1 112 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glutamate [NMDA] receptor subunit epsilon 2 467 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glutamate [NMDA] receptor subunit epsilon 3 47 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 331.49Molecular Weight (Monoisotopic): 331.1831AlogP: 2.82#Rotatable Bonds: 7
Polar Surface Area: 70.83Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.55CX Basic pKa: 9.29CX LogP: 3.44CX LogD: 1.56
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.60Np Likeness Score: -1.51

References

1. Gregory TF, Wright JL, Wise LD, Meltzer LT, Serpa KA, Konkoy CS, Whittemore ER, Woodward RM..  (2000)  Parallel synthesis of a series of subtype-selective NMDA receptor antagonists.,  10  (6): [PMID:10741546] [10.1016/s0960-894x(00)00035-4]

Source